NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
about
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemiaAntiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanismA NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignanciesNADPH oxidases and cancer.PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche.Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives.Therapeutic potential of NADPH oxidase 1/4 inhibitors.Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.Pleckstrin homology domain of p210 BCR-ABL interacts with cardiolipin to regulate its mitochondrial translocation and subsequent mitophagy.Targeting the duality of cancer.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.
P2860
Q33728096-E1DE8C31-5ACB-4A00-B9AE-04EAB17B3DD8Q35767081-D13B3229-C5F9-4FE8-B500-1E79C30AE60DQ36414254-7024BBBC-A0CE-429E-9DE5-34E7BCE6C824Q38394359-1FF2D038-B5A3-40EC-AE14-6FF13440DE9BQ38837361-CADF2640-FCB6-41A9-9E83-576B078F2C38Q38853680-87DFC3B2-B3A7-4A21-970F-417C333590BDQ38858553-FD34304A-8EC4-4531-9275-CA57FEEA2E3AQ38946587-E36981CC-19A8-4A70-BB6F-61AEBBA7E958Q45875437-5EA406D7-8C31-4F64-88B3-663ECC9404D5Q52539731-702670A8-1556-4FEA-BFE5-DC50BF4F26B1Q55503143-D79A1347-E09D-4A01-A1F2-D76FB3EC49AE
P2860
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@en
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@nl
type
label
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@en
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@nl
prefLabel
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@en
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
@nl
P2093
P50
P1476
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia
@en
P2093
Atanasio Pandiella
Beatriz Sánchez-Sánchez
Consuelo Del Cañizo
Guillermo López-Ruano
Jesús F San Miguel
Marcial Llanillo
Marta Romo-González
Rodrigo Prieto-Bermejo
Sara Gutiérrez-Herrero
P304
P356
10.1158/1078-0432.CCR-13-3044
P407
P577
2014-05-15T00:00:00Z